Price, Douglas K., Chau, Cindy H., Till, Cathee, Goodman, Phyllis J., Leach, Robin J., Johnson-Pais, Teresa L., Hsing, Ann W., Hoque, Ashraful, Parnes, Howard L., Schenk, Jeannette M., Tangen, Catherine M., Thompson, Ian M., Reichardt, Juergen K. V., and Figg, William D. (2016) Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: results from the Prostate Cancer Prevention Trial. Cancer, 122 (15). pp. 2332-2340.

Schenk, Jeannette, Till, Cathee, Hsing, Ann W., Stanczyk, Frank Z., Gong, Zhihong, Neuhouser, Marian L., Reichardt, Juergen K., Hoque, Ashraful M., Figg, William D., Goodman, Phyllis J., Tangen, Catherine M., and Thompson, Ian (2016) Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial. Cancer Causes and Control, 27 (2). pp. 175-182.

Hoque, Ashraful, Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen K.V., vanBokhoven, Adrie, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L., Lippman, Scott M., Ambrosone, Christine B., and Thompson, Ian (2015) Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease. Urology, 85 (3). pp. 616-620.

Chau, Cindy H., Price, Douglas K., Till, Cathee, Goodman, Phyllis J., Chen, Xiaohong, Leach, Robin J., Johnson-Pais, Teresa L., Hsing, Ann W., Hoque, Ashraful, Tangen, Catherine M., Chu, Lisa, Parnes, Howard L., Schenk, Jeannette M., Reichardt, Juergen K.V., Thompson, Ian M., and Figg, William D. (2015) Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PLoS One, 10 (5). e0126672.

Kristal, Alan R., Till, Cathee, Tangen, Catherine M., Goodman, Phyllis J., Neuhouser, Marion L., Stanczyk, Frank Z., Chu, Lisa W., Patel, Sherfaraz K., Thompson, Ian M., Reichardt, Juergen, Hoque, Ashraful, Platz, Elizabeth A., Figg, William D., Van Bokhoven, Adrie, Lippman, Scott M., and Hsing , Ann W. (2012) Associations of serum sex steroid hormone and 5α-androstane-3α, 17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride. Cancer Epidemiology, Biomarkers & Prevention, 21 (10). pp. 1823-1832.

Tang, Li, Yao, Song, Till, Cathee, Goodman, Phyllis J., Tangen, Catherine M., Wu, Yue, Kristal, Alan R., Platz, Elizabeth A., Neuhouser, Marian L., Stanczyk, Frank Z., Reichardt, Juergen, Santella, Regina M., Hsing, Ann, Hoque, Ashraful, Lippman, Scott M., Thompson, Ian M., and Ambrosone, Christine B, (2011) Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis, 32 (10). pp. 1500-1506.

Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen, Tang, Li, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L,, Lippman, Scott M., Thompson, Ian M., Ambrosone, Christine B., and Hoque, Ashraful (2011) Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer causes and control, 22 (8). pp. 1121-1131.